The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis

Journal of Vascular Research

Volumn 46, Issue 4, 2009, Pages 325-332

  Maciel, Thiago Trovati ^a,b   Melo, Rosilene Santos ^b   Campos, Alexandre Holthausen ^a  

^a Albert Einstein Research and Education Institute   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Bone morphogenetic proteins; Gremlin; Vascular injury; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CASPASE 3; DOBUTAMINE; GLYCOPROTEIN; GREMLIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BMP2 PROTEIN, RAT; BMP4 PROTEIN, RAT; CASP3 PROTEIN, RAT; CKTSF1B1 PROTEIN, RAT; MESSENGER RNA; OSTEOGENIC PROTEIN 1; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; MALE; MUSCLE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; CAROTID ARTERY INJURY; CELL CULTURE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; INJURY; METABOLISM; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; TIME;

ANGIOPLASTY, BALLOON; ANGIOTENSIN II; ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; CAROTID ARTERY INJURIES; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE MODELS, ANIMAL; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 58149361392     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189793     Document Type: Article

References (32)

1. Perlman H, Maillard L, Krasinski K, Walsh K: Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997;95:981-987.
2. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
3. Schwartz SM, Majesky MW, Murry CE: The intima: development and monoclonal responses to injury. Atherosclerosis 1995; 118(suppl):S125-S140.
4. Gibbons GH, Dzau VJ: The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431-1438.
5. Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995;147:267-277.
6. Pollman MJ, Hall JL, Gibbons GH: Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. Circ Res 1999;84:113-121.
7. Schwartz SM, deBlois D, O'Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465.
8. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, Fujita T: Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 1997;100:2824-2832.
9. Ducy P, Karsenty G: The family of bone morphogenetic proteins. Kidney Int 2000;57:2207-2214.
10. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-1809.
11. Hruska KA, Mathew S, Saab G: Bone morphogenetic proteins in vascular calcification. Circ Res 2005;97:105-114.
12. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584.
13. Balemans W, Van Hul W: Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002;250:231-250.
14. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998;1:673-683.
15. Maciel TT, Melo RS, Schor N, Campos AH: Gremlin promotes vascular smooth muscle cell proliferation and migration. J Mol Cell Cardiol 2008;44:370-379.
16. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993;90:8474-8478.
17. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH: Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res 1996;79:748-756.
18. Schwartz SM: The intima: a new soil. Circ Res 1999;85:877-879.
19. Li XA, Bianchi C, Sellke FW: Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB. J Surg Res 2001;100:197-204.
20. Matter CM, Chadjichristos CE, Meier P, von Lukowicz T, Lohmann C, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, Kwak BR, Luscher TF: Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation 2006;113:1879-1887.
21. Carter AJ, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R: Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-1405.
22. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
23. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 1991;88:904-910.
24. Bobik A: Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 2006;26:1712-1720.
25. Pollman MJ, Naumovski L, Gibbons GH: Vascular cell apoptosis: cell type-specific modulation by transforming growth factorbeta1 in endothelial cells versus smooth muscle cells. Circulation 1999;99:2019-2026.
26. Wilensky RL: Angiotensin-receptor blockers: revival of the systemic prevention of restenosis? Cardiovasc Drugs Ther 2003;17:63-73.
27. Serruys PW, Heyndrickx GR, Patel J, Cummins PA, Kleijne JA, Clowes AW: Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement. Int J Cardiovasc Intervent 2003;5:214-222.
28. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX: Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003; 285:L740-L754.
29. Willette RN, Gu JL, Lysko PG, Anderson KM, Minehart H, Yue T: BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res 1999;36:120-125.
30. Dorai H, Vukicevic S, Sampath TK: Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 2000;184:37-45.
31. Hsieh PC, Kenagy RD, Mulvihill ER, Jeanette JP, Wang X, Chang CM, Yao Z, Ruzzo WL, Justice S, Hudkins KL, Alpers CE, Berceli S, Clowes AW: Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy. J Vasc Surg 2006;43:150-158.
32. Corriere MA, Rogers CM, Eliason JL, Faulk J, Kume T, Hogan BL, Guzman RJ: Endothelial Bmp4 is induced during arterial remodeling: effects on smooth muscle cell migration and proliferation. J Surg Res 2008;145:142-149.